FINDINGS:
Comparison: 2023-08-12.
Pulmonary parenchyma: No focal consolidation or suspicious pulmonary nodules. No pneumothorax.
Mediastinum: Cardiomediastinal contours within normal limits.
Pleura/Pleural spaces: No pleural effusion or pleural thickening. trace effusion. no pleural nodularity.
Great vessels/Aorta: No thoracic aortic aneurysm or dissection.
Liver: No focal hepatic lesions. Normal attenuation. simple cyst.
Spleen: Normal in size and attenuation. No focal splenic lesion.
Pancreas: Normal pancreatic contour and enhancement. No focal mass. serous cystadenoma. no pancreatic mass.
Adrenal glands: Adrenal glands are normal without nodules.
Kidneys: 5.1 cm spiculated enhancing renal mass in the left kidney, interpolar. No hydronephrosis. No enhancing renal mass.
GI tract/Bowel: No obstructive process. No focal bowel wall mass identified. no colonic mass.
Mesentery/Omentum: 23 mm lesion in the peritoneum, suspicious for metastasis. No ascites. No omental caking.
Mesenteric vessels (SMA/SMV): SMA/SMV are patent without thrombosis.
Urinary bladder: Unremarkable.
Reproductive organs: No adnexal mass. Uterus/prostate within expected size for age. prostate is normal / no prostatic mass.
Lymph nodes: Enlarged mesenteric lymph node, short axis 3.0 cm. No pathologically enlarged lymph nodes by size criteria.
Bones/Osseous structures: No aggressive osseous lesion. No acute fracture. no destructive osseous lesion.

IMPRESSION:
- Kidney primary malignancy at left kidney, interpolar measuring approximately 51 mm.
- Findings concerning for nodal involvement.
- Findings compatible with distant metastases involving: peritoneum.
- RECIST 1.1 Summary:
- Target lesions (n=3; ≤2 per organ rule applied).
  • T1: Primary — 48→51 mm (longest diameter).
  • T2: Metastasis — 21→23 mm (longest diameter).
  • T3: Lymph node — 27→30 mm (short axis).
- SLD baseline: 96 mm.
- SLD current: 104 mm (+8.3% change).
- New lesions: absent (unequivocal).
- - RECIST 1.1 overall response category: PD.
